News

Jim DeLisi of Fanwood Chemical testified on behalf of SOCMA and hammered the main points that the statute will not require “sweeping change” and that Congress should look

Marinus Pharmaceuticals, a specialty pharmaceutical company, has met its primary endpoint for its Phase II clinical trial investigating the safety and efficacy of ganaxolone as adjunctive therapy in

PhotoMedex, which is engaged in the development, manufacturing and marketing of medical laser products and services, has completed the acquisition of Photo Therapeutics, a developer and provider of

The 2008 performance was primarily driven by sales of BioThrax (Anthrax Vaccine Adsorbed), the company’s FDA licensed vaccine for the prevention of anthrax, offset somewhat by a lower

Pfizer and Bausch & Lomb, an eye care company, have signed a co-promotion agreement involving both companies’ prescription ophthalmic pharmaceuticals in the US. The agreement will allow both

This will allow the company to open a Phase I study evaluating the safety of GGTI-2418 during the first quarter of 2009. GGTI-2418 is a synthetic peptidomimetic inhibitor

According to Aethlon, the Hemopurifier is a medical device that assists the immune response in combating infectious disease through real-time therapeutic filtration of infectious viruses and immunosuppressive proteins

Currently, Obe is chairman and CEO of Sysmex America, Inc. John Kershaw, who is presently serving as president and chief operating officer (COO) of Sysmex America, will be

According to BioImagene, Virtuoso is a comprehensive suite of web-based software applications that work with its iScan slide scanners to provide an end-to-end workflow solution. It is a